Phase I/II trial of low dose suramin (CI-1003, NSC#34936) and 5-fluorouracil in patients with metastatic renal cell carcinoma (RCC).
Phase of Trial: Phase I/II
Latest Information Update: 29 May 2015
At a glance
- Drugs Suramin sodium (Primary) ; Fluorouracil
- Indications Renal cancer
- Focus Pharmacokinetics; Therapeutic Use
- 11 May 2008 The expected completion date for this trial is now 1 Mar 2008.
- 11 May 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 10 Aug 2005 New trial record.